MAZE Maze Therapeutics Inc.
Health Care, filed as MAZE THERAPEUTICS INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
Who owns this now
Largest portfolio weights among holders, up to 0.4% (Nathan Fischel, DAFNA Capital Management). Not free-float ownership.
Who owns MAZE
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Farallon Capital Management | Hold | 1,107,814 | $30M | History | |
| Nathan Fischel, DAFNA Capital Management | Hold | 65,000 | $1.8M | History |
Insider trades
Open-market buys and sales by MAZE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.1M sold by 1 insider outside a trading plan
- $22.7M sold by 4 insiders under 10b5-1 plans
-
Jason V. Coloma CEOPlanned sale$1M 34,501 shares at $30.25 16% of stakeTraded Nov 2 Filed Nov 4
-
Atul Dandekar CsboPlanned sale$241K 7,500 shares at $32.07 19% of stakeTraded Oct 29 Filed Oct 30
-
Harold Bernstein President, R&D & CMOPlanned sale$435K 16,141 shares at $26.93 100% of stakeTraded Oct 1 Filed Oct 2
-
Jason V. Coloma CEOPlanned sale$932K 34,501 shares at $27.02 15% of stakeTraded Oct 1 Filed Oct 2
-
Atul Dandekar CsboPlanned sale$203K 7,500 shares at $27.06 19% of stakeTraded Sep 29 Filed Oct 1
-
Harold Bernstein President, R&D & CMOPlanned sale$255K 9,705 shares at $26.22 100% of stakeTraded Sep 4 Filed Sep 8
-
Harold Bernstein President, R&D & CMOPlanned sale$426K 16,141 shares at $26.36 100% of stakeTraded Sep 1 Filed Sep 3
-
Jason V. Coloma CEOPlanned sale$907K 34,501 shares at $26.29 13% of stakeTraded Sep 1 Filed Sep 3
-
Atul Dandekar CsboPlanned sale$207K 7,500 shares at $27.58 22% of stakeTraded Aug 28 Filed Aug 31
-
Harold Bernstein President, R&D & CMOPlanned sale$446K 16,142 shares at $27.61 100% of stakeTraded Aug 13 Filed Aug 14
-
Jason V. Coloma CEOPlanned sale$922K 34,501 shares at $26.73 12% of stakeTraded Aug 3 Filed Aug 5
-
Atul Dandekar CsboPlanned sale$205K 7,500 shares at $27.34 22% of stakeTraded Jul 29 Filed Jul 31
-
Harold Bernstein President, R&D & CMOPlanned sale$437K 14,609 shares at $29.90 100% of stakeTraded Jul 1 Filed Jul 2
-
Jason V. Coloma CEOPlanned sale$1M 34,501 shares at $29.98 11% of stakeTraded Jul 1 Filed Jul 2
-
Atul Dandekar CsboPlanned sale$210K 7,500 shares at $28.02 22% of stakeTraded Jun 29 Filed Jul 1
Also filed in the last 12 months, not counted as buying or selling: 49 option exercises, 16 sales to cover taxes, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 10 shown.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
| Metric | FY2025 |
|---|---|
| Net income | -$131.12M |
Balance sheet
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon